These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clarithromycin in coronary heart disease: excess mortality in the long term. Prescrire Int; 2006 Dec; 15(86):225. PubMed ID: 17167932 [TBL] [Abstract][Full Text] [Related]
9. Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study. Wuopio J; Hilden J; Bring C; Kastrup J; Sajadieh A; Jensen GB; Kjøller E; Kolmos HJ; Larsson A; Jakobsen JC; Winkel P; Gluud C; Carlsson AC; Ärnlöv J Atherosclerosis; 2018 Nov; 278():97-102. PubMed ID: 30261474 [TBL] [Abstract][Full Text] [Related]
10. Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective? Winkel P; Hilden J; Fischer Hansen J; Hildebrandt P; Kastrup J; Kolmos HJ; Kjøller E; Jespersen CM; Gluud C; Jensen GB; Cardiology; 2011; 118(1):63-7. PubMed ID: 21447948 [TBL] [Abstract][Full Text] [Related]
11. Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study. Ruge T; Carlsson AC; Kjøller E; Hilden J; Kolmos HJ; Sajadieh A; Kastrup J; Jensen GB; Larsson A; Nowak C; Jakobsen JC; Winkel P; Gluud C; Ärnlöv J Atherosclerosis; 2019 May; 284():202-208. PubMed ID: 30959314 [TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
13. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D; Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206 [TBL] [Abstract][Full Text] [Related]
14. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis. Gotfried M; Busman TA; Norris S; Notario GF Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study. Quinn J; Ruoff GE; Ziter PS Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505 [TBL] [Abstract][Full Text] [Related]
17. Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial. Giamarellos-Bourboulis EJ; Mylona V; Antonopoulou A; Tsangaris I; Koutelidakis I; Marioli A; Raftogiannis M; Kopterides P; Lymberopoulou K; Mouktaroudi M; Papageorgiou C; Papaziogas B; Georgopoulou AP; Tsaganos T; Papadomichelakis E; Gogos C; Ladas M; Savva A; Pelekanou A; Baziaka F; Koutoukas P; Kanni T; Spyridaki A; Maniatis N; Pelekanos N; Kotsaki A; Vaki I; Douzinas EE; Koratzanis G; Armaganidis A J Antimicrob Chemother; 2014 Apr; 69(4):1111-8. PubMed ID: 24292991 [TBL] [Abstract][Full Text] [Related]
18. Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. Berende A; ter Hofstede HJ; Vos FJ; van Middendorp H; Vogelaar ML; Tromp M; van den Hoogen FH; Donders AR; Evers AW; Kullberg BJ N Engl J Med; 2016 Mar; 374(13):1209-20. PubMed ID: 27028911 [TBL] [Abstract][Full Text] [Related]
19. Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial. Winkel P; Jakobsen JC; Hilden J; Lange T; Jensen GB; Kjøller E; Sajadieh A; Kastrup J; Kolmos HJ; Larsson A; Ärnlöv J; Gluud C Diagn Progn Res; 2017; 1():10. PubMed ID: 31093541 [TBL] [Abstract][Full Text] [Related]
20. Adverse events in people taking macrolide antibiotics versus placebo for any indication. Hansen MP; Scott AM; McCullough A; Thorning S; Aronson JK; Beller EM; Glasziou PP; Hoffmann TC; Clark J; Del Mar CB Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011825. PubMed ID: 30656650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]